17 articles for thisTarget
              
              The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Structure-Affinity Relationship Analysis of Selective FKBP51 Ligands.

Max Planck Institute of Psychiatry
 
Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52.

Max Planck Institute of Psychiatry
 
Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52.

Max Planck Institute of Psychiatry
 
Synthesis and evaluation of Glypsi(PO(2)R-N)Pro-containing pseudopeptides as novel inhibitors of the human cyclophilin hCyp-18.

Departement D'Ingenierie Et D'Etudes Des Proteines
 
Design of a Gag pentapeptide analogue that binds human cyclophilin A more efficiently than the entire capsid protein: new insights for the development of novel anti-HIV-1 drugs.

Departement D'Ingenierie Et D'Etudes Des Proteines
 
 
Synthesis and structure-activity relationships of macrocyclic FKBP ligands

TBA
 
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.

Johann Wolfgang Goethe University
 
Antascomicin B stabilizes FKBP51-Akt1 complexes as a molecular glue.

Technical University Darmstadt
 
Structure-based discovery of small molecule inhibitors of FKBP51-Hsp90 protein-protein interaction.

Karolinska Institutet
 
Macrocyclization strategy for improving candidate profiles in medicinal chemistry.

Gachon University
 
Structure-Based Discovery of a New Selectivity-Enabling Motif for the FK506-Binding Protein 51.

Technical University Darmstadt
 
Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.

University of Michigan
 
Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors.

Technical University Darmstadt
 
Bioinspired Hybrid Fluorescent Ligands for the FK1 Domain of FKBP52.

Paris-Sud University
 
Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBP12 with neuroregenerative properties.

Max-Planck Research Unit
 
Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins.

Max Planck Institute of Psychiatry
 
Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same

Arbutus Biopharma